XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2022 $ 12,507 $ 73,189,449 $ (69,004,926) $ 4,197,030
Beginning balance (in shares) at Dec. 31, 2022 12,506,795      
Net income 983,305 983,305
Issuance of common stock upon settlement of restricted stock, net $ 19 19
Issuance of common stock upon settlement of restricted stock, net (in shares) 19,247      
Stock-based compensation expense 338,904 338,904
Ending balance, value at Mar. 31, 2023 $ 12,526 73,528,353 (68,021,621) 5,519,258
Ending balance (in shares) at Mar. 31, 2023 12,526,042      
Beginning balance, value at Dec. 31, 2022 $ 12,507 73,189,449 (69,004,926) 4,197,030
Beginning balance (in shares) at Dec. 31, 2022 12,506,795      
Net income       2,441,745
Ending balance, value at Sep. 30, 2023 $ 12,761 73,849,050 (66,563,181) 7,298,630
Ending balance (in shares) at Sep. 30, 2023 12,760,331      
Beginning balance, value at Mar. 31, 2023 $ 12,526 73,528,353 (68,021,621) 5,519,258
Beginning balance (in shares) at Mar. 31, 2023 12,526,042      
Net income 1,157,076 1,157,076
Issuance of common stock upon settlement of restricted stock, net $ 201 201
Issuance of common stock upon settlement of restricted stock, net (in shares) 201,125      
Stock-based compensation expense 180,015 180,015
Ending balance, value at Jun. 30, 2023 $ 12,727 73,708,368 (66,864,545) 6,856,550
Ending balance (in shares) at Jun. 30, 2023 12,727,167      
Net income 301,364 301,364
Issuance of common stock upon settlement of restricted stock, net $ 34 34
Issuance of common stock upon settlement of restricted stock, net (in shares) 33,164      
Stock-based compensation expense 140,682 140,682
Ending balance, value at Sep. 30, 2023 $ 12,761 73,849,050 (66,563,181) 7,298,630
Ending balance (in shares) at Sep. 30, 2023 12,760,331      
Beginning balance, value at Dec. 31, 2023 $ 12,771 73,872,679 (51,803,722) $ 22,081,728
Beginning balance (in shares) at Dec. 31, 2023 12,771,434     12,771,434
Net income 168,238 $ 168,238
Issuance of common stock upon settlement of restricted stock, net $ 13 13
Issuance of common stock upon settlement of restricted stock, net (in shares) 13,334      
Stock-based compensation expense 281,510 281,510
Ending balance, value at Mar. 31, 2024 $ 12,784 74,154,189 (51,635,484) 22,531,489
Ending balance (in shares) at Mar. 31, 2024 12,784,768      
Beginning balance, value at Dec. 31, 2023 $ 12,771 73,872,679 (51,803,722) $ 22,081,728
Beginning balance (in shares) at Dec. 31, 2023 12,771,434     12,771,434
Net income       $ 2,327,861
Ending balance, value at Sep. 30, 2024 $ 12,933 74,402,288 (49,475,861) $ 24,939,360
Ending balance (in shares) at Sep. 30, 2024 12,933,408     12,933,408
Beginning balance, value at Mar. 31, 2024 $ 12,784 74,154,189 (51,635,484) $ 22,531,489
Beginning balance (in shares) at Mar. 31, 2024 12,784,768      
Net income 1,409,946 1,409,946
Issuance of common stock upon settlement of restricted stock, net $ 179 179
Issuance of common stock upon settlement of restricted stock, net (in shares) 178,095      
Stock-based compensation expense 175,356 175,356
Ending balance, value at Jun. 30, 2024 $ 12,963 74,329,545 (50,225,538) 24,116,970
Ending balance (in shares) at Jun. 30, 2024 12,962,863      
Net income 749,677 749,677
Issuance of common stock upon settlement of restricted stock, net $ (30) (30)
Issuance of common stock upon settlement of restricted stock, net (in shares) (29,455)      
Stock-based compensation expense 72,743 72,743
Ending balance, value at Sep. 30, 2024 $ 12,933 $ 74,402,288 $ (49,475,861) $ 24,939,360
Ending balance (in shares) at Sep. 30, 2024 12,933,408     12,933,408